Pyrogen Testing Market 2025 with Focus on Emerging Technologies, Global Trends, Competitive Landscape, Regional Analysis & Forecasts

2018-05-08 12:58:05

Pyrogen Testing: growing pharmaceutical and biotechnological industries to drive the pyrogen testing market


Market Overview

According to a new report published by Reports Monitor titled, “Pyrogen Testing Market by Product, Test, and Application: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the pyrogen testing market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. 


More Insightful Information | Request a Sample Copy @ https://bit.ly/2K4V749


Surging chronic diseases has led the increase in demand for pyrogen testing. Pyrogen is thermally stable bacterial toxin that produces rise in temperature in human or animal giving immunogenic response when administrated parenterally. The testing concludes the presence of pyrogen substance in vaccines, biotechnological products, food and drug. It is carried out during manufacturing process to prevent contamination and to make sure the absence of toxic molecular products.  


Rising industries of biotechnology and pharmaceutical companies across the globe is vital factor driving the growth of the pyrogen testing market. Huge investment in R&D for new product development, government initiatives and rising prevalence of chronic diseases further boost the market growth. Moreover, pyrogen testing being mandatory process for the approval of any sort drug or medication leads the expansion of the market. However, strict, administrative norms stand as restraint for the growth of the market. Growing industrialization of life science field and newly emerging markets in developing regions provide great opportunities for pyrogen testing market.  Pyrogen testing market in North America is positively affected by well-developed healthcare facilities and infrastructure and increase in R&D programmes. Additionally presence of large number of biotech and pharmaceutical companies such as Celgene Corp., F. Hoffmann-La Roche AG, Amgen Inc., and Pfizer Inc.


The global pyrogen testing market is segmented based on product, test, application and regions. On the basis of type the product is divided into Kits & reagent, instrument and services. In terms of test the market is distributed into Limulus Amoebocyte Lysate tests, In Vitro test, monocyte activation test and rabbit test. Depending upon application the market is divided into pharmaceutical and biological companies, medical device manufacturing, food and beverage and others.


Major players operating in the market are Hyglos GmbH, Charles River Laboratories, Inc., Thermo Fisher Scientific, Inc., Ellab A/S, Associates of Cape Cod, Inc., Lonza Group, Merck KGaA, Wako Chemicals USA Inc., GenScript, Wuxi PharmaTech Inc. and Pyrostar.


Different strategies such as new product launch, mergers, collaboration, acquisitions and geographical expansion for sufficing the unmet requirement of their customers. In July 2013, Hyglos GmbH announced Bioclass S.r.l. as new partner.  Under this agreement, Bioclass S.r.l. will be representing and selling Hyglos endotoxin removal systems and endotoxin detection assays in Italy.

This report presents a detailed evaluation of XXX market, which incorporates current industry situations such as market size, growth and demands, market outlook, major players with their key strategies which include investment, mergers and acquisitions, value chain analysis and porter’s evaluation. It covers the marketplace canvas and the boom opportunities in the coming years. The report has been made with an in-depth analysis along with vital inputs from the various industry professionals. The research is accomplished with both extensive primary and secondary data 


About Garner Insights:
We at Garner Insights.com provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us
Kevin Thomas
Direct:
+1 513 549 5911 (US)
+44 203 318 2846 (UK)

Related Press Releases